Advertisement
Advertisement

TNYA

TNYA logo

Tenaya Therapeutics, Inc. Common Stock

0.77
USD
Sponsored
-0.02
-2.03%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

0.78

0.00
+0.39%

TNYA Earnings Reports

Positive Surprise Ratio

TNYA beat 13 of 18 last estimates.

72%

Next Report

Date of Next Report
Mar 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.12
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
--
/
-57.14%

Tenaya Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, TNYA reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.15 USD, resulting in a 20.37% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +11.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.12 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Tenaya Therapeutics, Inc. Common Stock reported EPS of -$0.12, beating estimates by 20.37%, and revenue of $0.00, 0% as expectations.
The stock price moved up 11.72%, changed from $1.28 before the earnings release to $1.43 the day after.
The next earning report is scheduled for Mar 02, 2026.
Based on 10 analysts, Tenaya Therapeutics, Inc. Common Stock is expected to report EPS of -$0.12 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement